Keyphrases
After Surgery
12%
Assay Specificity
12%
Blood Test
12%
Breakage-fusion-bridge Cycle
7%
BRIP1
16%
Cancer Causes
12%
Cancer Mortality
12%
Cell-free DNA Analysis
12%
Chemotherapy
12%
Circulating Tumor DNA (ctDNA)
100%
Copy number mutation
7%
Disease Diagnosis
100%
DNA Assay
25%
DNA Detection
12%
DNA Repair Defect
7%
DNA Sequencing
100%
Epithelial Ovarian Cancer
100%
ERBB2 Amplification
10%
ERBB2 mutation
20%
Exon 4
7%
HER2 Alterations
100%
HER2 Assessment
10%
HER2 Pathway
10%
Hereditary Breast Cancer Syndromes
33%
Hereditary Leiomyomatosis
16%
High Sensitivity
12%
High Specificity
12%
High-grade Serous Cancer
12%
Li-Fraumeni Syndrome
33%
Mixed Cancer
100%
Online Treatment
12%
Ovarian Cancer Patients
12%
Ovary Syndrome
33%
Overall Survival
12%
Patient Analysis
12%
Physical Limits
12%
Plasma Cell-free DNA
12%
Plasma Samples
12%
Postoperative Residual
12%
Postoperative Surveillance
12%
Rapid Progression
12%
Recurrence Rate
12%
Residual Disease
100%
Screening Measure
16%
Survival Median
12%
Tailored Screening
16%
Tumor
12%
Tumor mutation Burden
12%
Ultrasensitive Assay
12%
Working Diagnosis
12%
Medicine and Dentistry
Cell-Free DNA
12%
Chloroplast DNA
100%
Circulating Tumor DNA
100%
Diseases
12%
DNA Determination
25%
Krukenberg Tumor
100%
Leiomyomatosis
16%
Li-Fraumeni Syndrome
33%
Malignant Neoplasm
25%
Minimal Residual Disease
100%
Neoplasm
25%
Overall Survival
12%
Recurrent Disease
12%
Sensitivity and Specificity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
12%
Chloroplast DNA
100%
Circulating Tumor DNA
100%
Diseases
12%
Malignant Neoplasm
25%
Minimal Residual Disease
100%
Neoplasm
25%
Ovary Carcinoma
100%
Overall Survival
12%
Recurrent Disease
12%
